方正科技(600601.SH):回函稱北大資產擬為方正集團引入大型央企作為戰略投資人
格隆匯12月3日丨方正科技(600601.SH)公佈,近日有媒體報道稱“從北大資產公司獲悉,按照中央關於高校所屬企業體制改革的相關部署,北大資產公司目前擬為方正集團引入的戰略投資人為大型央企。”
經公司書面函證,方正集團回函稱:“經向我司控股股東北大資產瞭解,按照中央關於高校所屬企業體制改革的相關部署,北大資產擬為方正集團引入大型央企作為戰略投資人。北大資產正就此事與各方緊密溝通,目前尚未最終確定戰略合作方及具體交易方案,後續能否順利推進存在重大不確定性。一旦最終確定,方正集團實際控制人將可能發生變化。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.